“ultragenyx-pharmaceutical” Archives

in
Entry Author Date Location
Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder 06/30/20 San Francisco
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Palforzia Peanut Allergy Immunotherapy: Aimmune CEO on REMS, Manufacturing 03/24/20 National
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
After FDA Approves Bone Disease Drug, Ultragenyx Sets $200K Price 04/17/18 San Francisco
Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More 12/22/17 National
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Ultragenyx Sweetens Offer, Dimension Tx Agrees to $151M Acquisition 10/03/17 San Francisco
Ultragenyx Makes Competing Bid for Gene Therapy Biotech Dimension Tx 09/18/17 San Francisco
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand 08/25/17 National
West Coast Biotech Roundup: Receptos, ProNAi, Protagonist & More 07/16/15 San Diego
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
West Coast Biotech Roundup: Genentech, CareDx, and More 07/17/14 San Diego
West Coast Biotech Roundup: Affymax, K2, Roche/Stratos, & More 06/26/14 San Francisco
Ultragenyx Pharmaceutical Obtains $121,000,000 New Financing 01/31/14 San Francisco
The Best Biotech Graduate Schools in Real Life 09/23/13 National
Ultragenyx, Led by BioMarin Vet, Snags $75M for Ultra-Rare Diseases 12/20/12 San Francisco
Ultragenyx Pharmaceutical Obtains $75,000,000 Series B Round 12/20/12 San Francisco
Ultragenyx Pharmaceutical Lands $45,000,000 Series A Round 06/20/11 San Francisco
Page 1 of 1